Loading viewer...
investor_presentation
Format: PDF investor_presentation
This presentation summarizes key terms of pro forma financial statements and the Loss Protection Agreement related to UBS's acquisition of Credit Suisse, including capital requirements and regulatory terms. It covers pro forma financials, loss protection mechanisms covering CHF 44bn of leverage ratio denominator, and regulatory capital surcharge phasing. The document details purchase accounting adjustments effective post-acquisition and supervisory expectations for liquidity coverage.
Sudarshan Pharma Industries Investor Presentation IPO
investor_presentationinvestor_presentation
46 Pages
Sudarshan Pharma Industries Ltd
brochure
AFLAC
Teva Pharmaceutical Industries Investor Presentation — July 2024
investor_presentationinvestor_presentation
57 Pages
Teva Pharmaceutical Industries